| APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in the rRNA quality control process C Vascotto, D Fantini, M Romanello, L Cesaratto, M Deganuto, ... Molecular and cellular biology, 2009 | 263 | 2009 |
| Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy L Wang, Z Zhao, PA Ozark, D Fantini, SA Marshall, EJ Rendleman, ... Nature medicine 24 (6), 758-769, 2018 | 151 | 2018 |
| Understanding different functions of mammalian AP endonuclease (APE1) as a promising tool for cancer treatment G Tell, D Fantini, F Quadrifoglio Cellular and Molecular Life Sciences 67, 3589-3608, 2010 | 148 | 2010 |
| A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer D Fantini, AP Glaser, KJ Rimar, Y Wang, M Schipma, N Varghese, ... Oncogene 37 (14), 1911-1925, 2018 | 128 | 2018 |
| Critical lysine residues within the overlooked N-terminal domain of human APE1 regulate its biological functions D Fantini, C Vascotto, D Marasco, C D’ambrosio, M Romanello, ... Nucleic acids research 38 (22), 8239-8256, 2010 | 124 | 2010 |
| The evolving genomic landscape of urothelial carcinoma AP Glaser, D Fantini, A Shilatifard, EM Schaeffer, JJ Meeks Nature Reviews Urology 14 (4), 215-229, 2017 | 120 | 2017 |
| APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response AP Glaser, D Fantini, Y Wang, Y Yu, KJ Rimar, JR Podojil, SD Miller, ... Oncotarget 9 (4), 4537, 2018 | 109 | 2018 |
| Identification of differential tumor subtypes of T1 bladder cancer AG Robertson, CS Groeneveld, B Jordan, X Lin, KA McLaughlin, A Das, ... European urology 78 (4), 533-537, 2020 | 89 | 2020 |
| APE1/Ref-1 regulates PTEN expression mediated by Egr-1 D Fantini, D Fantini, C Vascotto, M Deganuto, N Bivi, S Gustincich, ... Free radical research 42 (1), 20-29, 2008 | 81 | 2008 |
| The prion protein is critical for DNA repair and cell survival after genotoxic stress A Bravard, F Auvré, D Fantini, J Bernardino-Sgherri, L Sissoëff, M Daynac, ... Nucleic acids research 43 (2), 904-916, 2015 | 59 | 2015 |
| Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple … T Dörner, Y Tanaka, MA Petri, JS Smolen, DJ Wallace, ER Dow, RE Higgs, ... Lupus Science & Medicine 7 (1), e000424, 2020 | 49 | 2020 |
| easyPubMed: Search and retrieve scientific publication records from PubMed D Fantini R package version 2, 2019 | 44 | 2019 |
| Rapid inactivation and proteasome-mediated degradation of OGG1 contribute to the synergistic effect of hyperthermia on genotoxic treatments D Fantini, E Moritz, F Auvré, R Amouroux, A Campalans, B Epe, A Bravard, ... DNA repair 12 (3), 227-237, 2013 | 44 | 2013 |
| MutSignatures: an R package for extraction and analysis of cancer mutational signatures D Fantini, V Vidimar, Y Yu, S Condello, JJ Meeks Scientific Reports 10 (1), 18217, 2020 | 40 | 2020 |
| Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features XA Zhou, J Yang, KG Ringbloom, ME Martinez-Escala, KE Stevenson, ... Blood Advances 5 (3), 649-661, 2021 | 32 | 2021 |
| DDB2 is a novel regulator of Wnt signaling in colon cancer S Huang, D Fantini, BJ Merrill, S Bagchi, G Guzman, P Raychaudhuri Cancer research 77 (23), 6562-6575, 2017 | 31 | 2017 |
| Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma JR Podojil, AP Glaser, D Baker, ET Courtois, D Fantini, Y Yu, V Eaton, ... Oncoimmunology 9 (1), 1744897, 2020 | 30 | 2020 |
| Molecular footprints of muscle-invasive bladder cancer in smoking and nonsmoking patients D Fantini, R Seiler, JJ Meeks Urologic Oncology: Seminars and Original Investigations 37 (11), 818-825, 2019 | 30 | 2019 |
| Chromatin recruitment of OGG1 requires cohesin and mediator and is essential for efficient 8-oxoG removal E Lebraud, G Pinna, C Siberchicot, J Depagne, D Busso, D Fantini, ... Nucleic acids research 48 (16), 9082-9097, 2020 | 19 | 2020 |
| Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma A Piunti, K Meghani, Y Yu, AG Robertson, JR Podojil, KA McLaughlin, ... Science advances 8 (40), eabo8043, 2022 | 17 | 2022 |
